Patton Albertson Miller Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.13M Buy
39,923
+639
+2% +$74.8K 0.51% 60
2026
Q1
$4.73M Sell
39,284
-475
-1% -$54.8K 0.56% 58
2025
Q4
$4.19M Sell
39,759
-5,744
-13% -$539K 0.49% 65
2025
Q3
$3.82M Buy
45,503
+3,953
+10% +$326K 0.46% 70
2025
Q2
$3.29M Sell
41,550
-762
-2% -$60.6K 0.43% 75
2025
Q1
$3.8M Sell
42,312
-23,005
-35% -$2.15M 0.56% 62
2024
Q4
$6.5M Buy
65,317
+3,751
+6% +$387K 0.87% 45
2024
Q3
$6.99M Buy
61,566
+372
+0.6% +$44.2K 0.95% 42
2024
Q2
$7.58M Buy
61,194
+4,343
+8% +$559K 1.08% 32
2024
Q1
$7.5M Buy
56,851
+3,819
+7% +$471K 1.12% 27
2023
Q4
$5.78M Buy
53,032
+7,758
+17% +$805K 0.96% 38
2023
Q3
$4.66M Buy
45,274
+808
+2% +$87.1K 0.91% 32
2023
Q2
$5.13M Sell
44,466
-395
-0.9% -$44.8K 0.99% 27
2023
Q1
$4.77M Buy
44,861
+2,874
+7% +$310K 0.87% 36
2022
Q4
$4.66M Buy
41,987
+1,155
+3% +$118K 0.86% 34
2022
Q3
$3.52M Buy
40,832
+1,888
+5% +$169K 0.76% 43
2022
Q2
$3.55M Buy
38,944
+4,170
+12% +$370K 0.73% 43
2022
Q1
$2.85M Buy
34,774
+3,061
+10% +$241K 0.49% 74
2021
Q4
$2.43M Sell
31,713
-4,423
-12% -$352K 0.39% 84
2021
Q3
$2.71M Buy
36,136
+1,273
+4% +$96.8K 0.52% 69
2021
Q2
$2.71M Sell
34,863
-4,248
-11% -$316K 0.62% 61
2021
Q1
$2.88M Sell
39,111
-27,539
-41% -$2.03M 0.7% 54
2020
Q4
$4.72M Sell
66,650
-2,547
-4% -$195K 1.12% 17
2020
Q3
$5.48M Sell
69,197
-1,274
-2% -$99.8K 1.55% 10
2020
Q2
$5.2M Buy
70,471
+3,326
+5% +$250K 1.51% 10
2020
Q1
$4.93M Buy
67,145
+19,485
+41% +$1.53M 1.67% 7
2019
Q4
$4.14M Sell
47,660
-844
-2% -$69.3K 1.08% 15
2019
Q3
$3.9M Buy
48,504
+25,868
+114% +$2.07M 1.1% 14
2019
Q2
$1.85M Buy
22,636
+19,783
+693% +$1.51M 0.53% 61
2019
Q1
$226K Sell
2,853
-52
-2% -$3.89K 0.11% 112
2018
Q4
$213K Sell
2,905
-28,959
-91% -$2.04M 0.11% 116
2018
Q3
$2.15M Sell
31,864
-37
-0.1% -$2.36K 1.09% 15
2018
Q2
$1.85M Buy
+31,901
New +$1.8M 0.93% 30
2017
Q4
Sell
-3,273
Closed -$202K 128
2017
Q3
$202K Sell
3,273
-37
-1% -$2.24K 0.09% 127
2017
Q2
$202K Sell
3,310
-296
-8% -$18K 0.09% 126
2017
Q1
$218K Sell
3,606
-209
-5% -$12.7K 0.09% 129
2016
Q4
$214K Buy
3,815
+456
+14% +$26.7K 0.09% 128
2016
Q3
$200K Buy
+3,359
New +$196K 0.09% 130
2015
Q2
Sell
-4,954
Closed -$272K 137
2015
Q1
$272K Buy
4,954
+343
+7% +$19.4K 0.11% 128
2014
Q4
$250K Buy
4,611
+390
+9% +$21.7K 0.12% 141
2014
Q3
$239K Sell
4,221
-415
-9% -$23.3K 0.12% 142
2014
Q2
$255K Buy
4,636
+70
+2% +$3.82K 0.13% 146
2014
Q1
$247K Sell
4,566
-14
-0.3% -$725 0.13% 150
2013
Q4
$219K Buy
4,580
+75
+2% +$3.43K 0.13% 127
2013
Q3
$205K Buy
+4,505
New +$206K 0.12% 117

Other funds holding MRK

Patton Albertson Miller Group's MRK Position: Q2 2026 in Review

Patton Albertson Miller Group increased its Merck (MRK) stake by 1.6% in Q2 2026, buying an estimated $74.8K and bringing the position to 39,923 shares worth $5.13M. The position accounts for 0.51% of the portfolio, ranked #60.

Patton Albertson Miller Group first reported a position in MRK in Q3 2013 and has held it in 45 quarters since. The position peaked at $7.58M in Q2 2024. 1,341 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Patton Albertson Miller Group held 39,923 shares of Merck worth $5.13M as of Q2 2026.
  • Patton Albertson Miller Group bought 639 Merck shares in Q2 2026, an estimated $74.8K.
  • Merck made up 0.51% of Patton Albertson Miller Group's portfolio in Q2 2026, its #60 holding.
  • Patton Albertson Miller Group first reported a position in Merck in Q3 2013 and has held it in 45 quarters since.
  • Patton Albertson Miller Group's Merck position peaked at $7.58M in Q2 2024.
  • 1,341 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Patton Albertson Miller Group's 13F filing for Q2 2026, filed 22 Jul 2026.